High Burden of Incidental and High-Grade Prostatic Carcinoma in Transurethral Resection of the Prostate (TURP) Specimens: A Retrospective Histopathological Analysis From Central India

经尿道前列腺切除术 (TURP) 标本中偶发性和高级别前列腺癌的高发率:来自印度中部的一项回顾性组织病理学分析

阅读:2

Abstract

INTRODUCTION: The histopathological evaluation of transurethral resection of the prostate (TURP) chips, primarily performed for benign prostatic hyperplasia (BPH), remains critical for the incidental detection of pre-malignant and malignant prostatic lesions in resource-limited settings lacking comprehensive screening. This study aimed to characterize the histopathological spectrum of prostatic pathology and the severity of incidentally detected cancer in a rural area of Central India. METHODS: This was a single-center, retrospective study analyzing 218 consecutive TURP chip specimens received between July 2024 and November 2025. Data, including histopathological diagnosis, age distribution, and International Society of Urological Pathology (ISUP) 2014 Grade Group (GG) for incidental carcinoma, were collected. The Pearson Chi-square test was used to assess the association between age and malignancy. RESULTS: Out of 218 specimens, 75.68% (n = 165) were benign, and 18.36% (n = 40) were malignant. The prevalence of incidental prostatic adenocarcinoma (IPCa) was high at 17.90% (39 cases). Crucially, 53.8% (n = 21) of these adenocarcinomas were classified as aggressive (Grade Group 3 or higher), indicating a substantial burden of intermediate-to-high-grade disease. A statistically significant association was found between age and the presence of malignancy (Chi-square = 12.06, df = 4, p = 0.017). The highest proportional malignancy rate (62.5%) was noted in the youngest age group (<50 years). CONCLUSION: The exceptionally high prevalence of incidental carcinoma and the significant proportion of high-grade disease (GG ≥ 3) underscore the necessity of mandatory and thorough histopathological evaluation of all TURP specimens, irrespective of pre-operative clinical findings, especially considering the high malignancy rate in younger men (<50 years), to ensure timely diagnosis and aggressive management in this population.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。